EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms

Sule Canberk, João Gonçalves, Elisabete Rios, Antónia A Povoa, Ebru Tastekin, Manuel Sobrinho-Simões, Aysun Uguz, Ozlem Aydin, Umit Ince, Paula Soares, Valdemar Máximo

Endocrine Pathology · 2024

DOI: 10.1007/s12022-024-09800-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Pathology, 2024. Verfasst von Sule Canberk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT-Fundação para a Ciência e a Tecnologia-, FCT—Fundação para a Ciência e a Tecnologia—, Universidade do Porto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytosine modifications at the 5-carbon position play a critical role in gene expression regulation and have been implicated in cancer development. 5-Hydroxymethylcytosine (5hmC), arising from 5-methylcytosine (5-mC) oxidation, has shown promise as a potential malignancy marker due to its depletion in various human cancers. However, its significance in thyroid tumors remains underexplored, primarily due to limited data. In our study, we evaluated 5hmC expression levels by immunohistochemistry in a cohort of 318 thyroid tumors. Our analysis revealed significant correlations between 5hmC staining extension scores and nodule size, vascular invasion, and oncocytic morphology. Nuclear 5hmC staining intensity demonstrated associations with focality, capsule status, extrathyroidal extension, vascular invasion, and oncocytic morphology. Follicular/oncocytic adenomas exhibited higher 5hmC expression than uncertain malignant potential (UMP) or noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP), as well as malignant neoplasms, including papillary thyroid carcinomas (PTCs), oncocytic carcinomas (OCAs), follicular thyroid carcinomas (FTCs), and invasive encapsulated follicular variants of PTC (IEFV-PTC). TERT promoter mutation cases showed notably lower values for the 5hmC expression, while RAS ( H , N , or K ) mutations, particularly HRAS mutations, were associated with higher 5hmC expression. Additionally, we identified, for the first time, a significant link between 5hmC expression and oncocytic morphology. However, despite the merits of these discoveries, we acknowledge that 5hmC currently cannot segregate minimally invasive from widely invasive tumors, although 5hmC levels were lower in wi-FPTCs. Further research is needed to explore the potential clinical implications of 5hmC in thyroid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinoma, FollicularHumans5-MethylcytosineBiomarkers, TumorEpigenesis, Genetic

Stichwörter der Autor:innen

5hmCEpigeneticsHürthle cell tumorOncocytic cell tumorsThyroid tumors

Substanzen

5-hydroxymethylcytosine5-MethylcytosineBiomarkers, Tumor

Autor:innen und Institutionen

  • Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.
  • Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Rua Júlio Amaral de Carvalho 45, 4200-135, Porto, Portugal.
  • Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal.
  • Faculty of Medicine of the University of Porto (FMUP), Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal.
  • Department of Pathology, Faculty of Medicine of the University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
  • Department of General Surgery, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), 4434-502, Vila Nova de Gaia, Portugal.

Förderung

  • FCT-Fundação para a Ciência e a Tecnologia-
  • FCT—Fundação para a Ciência e a Tecnologia—
  • Universidade do Porto

Zitieren

APA

Canberk, S., Gonçalves, J., Rios, E., Povoa, A. A., Tastekin, E., Sobrinho-Simões, M., Uguz, A., Aydin, O., Ince, U., Soares, P., & Máximo, V. (2024). The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms. Endocrine Pathology. https://doi.org/10.1007/s12022-024-09800-9

Vancouver

Canberk S, Gonçalves J, Rios E, Povoa AA, Tastekin E, Sobrinho-Simões M, et al. The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms. Endocrine Pathology. 2024. doi:10.1007/s12022-024-09800-9

BibTeX
@article{Canberk2024,
  author = {Canberk, Sule and Gonçalves, João and Rios, Elisabete and Povoa, Antónia A and Tastekin, Ebru and Sobrinho-Simões, Manuel and Uguz, Aysun and Aydin, Ozlem and Ince, Umit and Soares, Paula and Máximo, Valdemar},
  title = {The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms},
  journal = {Endocrine Pathology},
  year = {2024},
  doi = {10.1007/s12022-024-09800-9}
}
Kostenlos starten →